Public-registry site landscape for NCT02867358, a Influenza, Human study sponsored by Yiling Pharmaceutical Inc.. All data below is from public sources; Eichor is not affiliated with the sponsor.
| Trial | NCT02867358 (registry record) |
| Sponsor | Yiling Pharmaceutical Inc. |
| Condition(s) | Influenza, Human |
| Phase | PHASE2 |
| Listed sites | 81 |
| Site countries | United States |
Eichor generates a preliminary site-risk snapshot for NCT02867358 — how the roster screens on competing-trial load, enrollment track record, and PI–indication fit — free, usually same day. Request it here →